The research will look for alternatives to standard antibiotics, which are losing their effectiveness against common infectious agents. Health experts worldwide are concerned about the spread of antibiotic-resistant microbial infections and the shrinking arsenal of compounds that can effectively treat them.
The five-year effort will explore the medical potential of a class of compounds called phosphonates. These compounds already have shown promise in treating infectious diseases such as malaria, and may also be useful in managing some chronic medical conditions. Phosphonates work by inhibiting cellular processes that involve naturally occurring phosphorylated compounds.
"There is the potential to discover a phosphonate inhibitor for every biochemical pathway that involves phosphorylated intermediates," said microbiology professor William W. Metcalf, a principal investigator on the study. "Because these compounds are widespread in biological processes, the range of targets is very large."
Metcalf is one of five principal investigators at the U. of I., all of whom have appointments at the Institute for Genomic Biology. His collaborators are William H. and Janet Lycan professor of chemistry Willem (Wilfred) A. van der Donk, chemical and biomolecular engineering professor Huimin Zhao, chemistry professor Neil Kelleher and biochemistry professor Satish Nair, of the Center for Biophysics and Computational Biology. Jo Handelsman, of the University of Wisconsin, also will contribute to the effort.
Metcalf, a microbial geneticist, has long been intrigued by bacterial phosphate metabolism. He has discovered and biochemically characterized a number of previously unknown enzymes involved in the microbial metabolism of phosphate compounds.
About 70 percent of the antibiotics currently in use come from bacteria. Metcalf's fascination with the ongoing "biological warfare between bacteria" led him to explore the antimicrobial potential of phosphonates. While phosphonates have found uses in medicine - to treat malaria or hypertension - this area of research is fairly new, he said.
"No one has even made a dedicated search for phosphonates in nature," he said.Metcalf and his collaborators have analyzed the biological activity of some known phosphonates,such as the herbicide phosphinothricin.
The van der Donk and Zhao groups have investigated the clinically used phosphonate, fosfomycin.
Kelleher, a biological mass spectroscopist, has constructed several new, high-resolution Fourier Transform mass spectrometers, which will help the researchers isolate previously unknown microbial products that contain the phosphonate group.
Nair is an X-ray crystallographer with expertise in elucidating the three-dimensional structure of protein and DNA complexes.
The research team has four goals: the discovery and genetic characterization of phosphonate biosynthetic pathways; the biochemical reconstruction of those pathways that have antibiotic or other therapeutic potential; the bioengineering of medically useful phosphonates and their biosynthetic enzymes for economical production; and the use of the latest mass spectrometric technology to discover and engineer phosphonates and enzymes that contribute to phosphonate metabolism.
"Our role is the discovery of antibiotics for which there is a critical need and the development of ways to produce these antibiotics economically," Metcalf said.
Diana Yates | University of Illinois
Rutgers scientists discover 'Legos of life'
23.01.2018 | Rutgers University
Researchers identify a protein that keeps metastatic breast cancer cells dormant
23.01.2018 | Institute for Research in Biomedicine (IRB Barcelona)
Physicists have developed a technique based on optical microscopy that can be used to create images of atoms on the nanoscale. In particular, the new method allows the imaging of quantum dots in a semiconductor chip. Together with colleagues from the University of Bochum, scientists from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute reported the findings in the journal Nature Photonics.
Microscopes allow us to see structures that are otherwise invisible to the human eye. However, conventional optical microscopes cannot be used to image...
On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.
We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...
What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...
For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.
Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...
At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.
No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
23.01.2018 | Life Sciences
23.01.2018 | Earth Sciences
23.01.2018 | Physics and Astronomy